Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Global Markets for 3D Cultures and Organoids: Trends Analysis with Forecast

This image opens in the lightbox

News provided by

BCC Research LLC

12 Mar, 2025, 18:18 GMT

Share this article

Share toX

Share this article

Share toX

"The market for lab models, 3D cultures, and organoids is rapidly growing, driven by new technology and the need for alternatives to animal testing in research."

BOSTON, March 12, 2025 /PRNewswire/ -- According to the latest study from BCC Research, the demand for Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets is expected to increase from $2.8 billion in 2024 to $5.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.

This report explores the global market for laboratory animal models, 3D cultures and organoids, covering major companies, trends, and regional markets. It provides market data from 2023, forecasts through 2029, and analyzes market drivers, restraints, opportunities, and regulatory factors. The report segments the market by type, application, end user, and regions, and analyzes the leading companies and their market shares.

Interesting facts 

The market for lab models, 3D cultures, and organoids is driven by 3D technologies that mimic human tissues, reduce the need for animal testing, and improve drug discovery.

Factors contributing to the growth include:

1.      Growing Focus on Ethical Alternatives to Animal Testing: There is a growing shift towards ethical alternatives to animal testing, such as 3D cultures and organoids, to make research more humane. These methods offer accurate results while reducing the need for animal use.

2.      Increasing Demand for Tumor Modeling and Biobanking: The demand for tumor modeling and biobanking is growing because they help in cancer research and drug development. This increased need is driving the expansion of the market for these technologies.

3.      Increasing Adoption of Organoid Technology: Organoid technology is being used more widely for research and drug testing because it closely mimics human organs. This growing adoption is expanding its applications in medical and scientific fields.

Request a Sample Copy of the Report Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets

Report Synopsis

Report Metric

Details

Base year considered

2023

Forecast period considered

2024-2029

Base year market size

$2.5 billion

Market size forecast

$5.0 billion

Growth rate

CAGR of 12.5% for the forecast period of 2024-2029

Segments covered

Animal Model, 3D cell Culture, Applications

Regions covered

North America, Europe, Asia-Pacific, Rest of the World, Middle East and Africa, South America

Countries covered

The U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Switzerland, Denmark, Belgium, the Netherlands, Sweden, Russia, China, Japan, Australia, South Korea, India, New Zealand, Singapore, Malaysia, Thailand, Indonesia, South Africa, GCC Countries, Brazil, Argentina, Colombia, Paraguay, Peru

Market drivers

•         Growing focus on ethical alternatives to animal testing

•         Increasing demand for tumor modeling and biobanking

•         Increasing adoption of organoid technology

This report addresses the following questions:

1.      What is the projected market size and growth rate?

The global market for laboratory animal models, 3D cultures, and organoids was valued at $2.5 billion in 2023 and is projected to reach $5.0 billion by the end of 2029.

2.      What factors are driving the growth of the market?

The growing focus on ethical alternatives to animal testing, increasing demand for tumor modeling and biobanking, and growing adoption of organoid technology.

3.      Which market segments are covered in the report?

This report analyzes the market based by animal model, 3D cell culture, type and application, end user, and region.

4.      Which technology segment will be dominant in 2029?

3D cell culture will have the largest share of the market.

5.      Which region has the highest share in the market?

The North American market was valued at $1.4 billion in 2023 and is projected to reach $2.9 billion by the end of 2029, at a CAGR of 12.7% during the forecast period. 

Market leaders include:

•         3D Biotek LLC

•         Bio-Techne

•         Cellink

•         Charles River Laboratories

•         Cherry Biotech

•         Corning Inc.

•         Emulate Inc.

•         Genoway

•         Greiner Bio-One International GmbH

•         InSphero

•         Mattek

•         Mimetas B.V.

•         Pepgel LLC

•         Poietis

•         Taconic Biosciences Inc.

•         Thewell Bioscience Inc.

•         Thermo Fisher Scientific Inc.

Related reports include:

Induced Pluripotent Stem Cells: Global Markets: Induced pluripotent stem cells (iPSCs) are cells that can turn into any type of cell in the body, making them valuable for research and treatments. The global market for iPSCs is growing as they offer new possibilities for personalized medicine and disease research.

3D Cell Cultures: Technologies and Global Markets: 3D cell cultures are lab-grown cells that mimic the structure of real tissues, improving research and drug testing. The global market for these technologies is growing as they offer more accurate results than traditional 2D cultures.

Purchase a copy of the report direct from BCC Research.

For further information on these reports or to purchase one, please contact info@bccresearch.com.

About BCC Research 

BCC Research market research reports provide objective, unbiased measurement and assessment of market opportunities. Our experienced industry analysts' goal is to help readers make informed business decisions, free of noise and hype.

Contact Us

Corporate HQ: 50 Milk St., Ste. 16, Boston, MA 02109, USA

Email: info@bccresearch.com

Phone: +1 781-489-7301

For media inquiries, email press@bccresearch.com or visit our media page for access to our market research library.

Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.

Modal title

Also from this source

BCC Research Forecasts Neurology Market to Reach $94.8 Billion by 2029

BCC Research Forecasts Neurology Market to Reach $94.8 Billion by 2029

According to the latest study from BCC Research, "Neurology Market: A BCC Research Overview" is estimated to increase from $67.3 billion in 2024 to...

Carbon Capture & Storage: The Key to a Greener Future

Carbon Capture & Storage: The Key to a Greener Future

According to the latest study from BCC Research, the demand for Carbon Capture, Utilization & Storage Technologies is grow from $3.4 billion in 2024...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Biotechnology

Biotechnology

Publishing & Information Services

Publishing & Information Services

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.